With the analysis among 5,692 patents, we discovered top 442 key players by total patent application. ViiV Healthcare UK (No. 4) Ltd., Gilead Sciences, Inc., F. Hoffmann-La Roche Ltd. are dominant in this area. They take 12.39% of the total patent filing.
ViiV Healthcare UK (No. 4) Ltd.
United Kingdom
Patent: 267
California, United States
Patent: 264
F. Hoffmann-La Roche Ltd.
New Jersey, United States
Patent: 125
Illinois, United States
Patent: 108
New York, United States
Patent: 91
New York, United States
Patent: 84
Pennsylvania, United States
Patent: 84
Janssen Vaccines & Prevention BV
Zuid-Holland, Netherlands
Patent: 83
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 72
With the analysis among 81 patents, we discovered top 11 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Excision BioTherapeutics, Inc., Mirror Biologics Inc are active in this area.
Institut National de la Santé et de la Recherche Médicale
Excision BioTherapeutics, Inc.
Pennsylvania, United States
Patent: 4
North Carolina, United States
Patent: 2
California, United States
Patent: 2
New Jersey, United States
Patent: 1
California, United States
Patent: 1
Guangzhou HEAS BioTech Co., Ltd.
Guangdong Sheng, China
Patent: 1
Genève, Switzerland
Patent: 1
With the analysis among related 548 patents applied in the last 5 years. We discover 165 most active companies in this area. The fast-growing ViiV Healthcare UK (No. 4) Ltd., Gilead Sciences, Inc., Janssen Vaccines & Prevention BV take 35.40% of patent filing during this period.
ViiV Healthcare UK (No. 4) Ltd.
United Kingdom
Patent: 108
California, United States
Patent: 61
Janssen Vaccines & Prevention BV
Zuid-Holland, Netherlands
Patent: 25
Shandong Sheng, China
Patent: 23
The Scripps Research Institute
California, United States
Patent: 14
Beth Israel Deaconess Medical Center, Inc.
Massachusetts, United States
Patent: 12
undefined undefined
Patent: 10
Regents of the University of California
California, United States
Patent: 8
With the analysis among related 548 patents in last 5 years, we discover 79 new entrants. Pharmasyntez JSC, Kancera AB, Cidara Therapeutics, Inc. are the most active new entrants in this area.
undefined undefined
Patent: 10
Cidara Therapeutics, Inc.
California, United States
Patent: 8
Grifols Diagnostic Solutions, Inc.
California, United States
Patent: 6
Yunnan Sheng, China
Patent: 6
New York, United States
Patent: 6
Texas Tech University System
Texas, United States
Patent: 5
Nordrhein-Westfalen, Germany
Patent: 4
Jiangsu University of Technology
Jiangsu Sheng, China
Patent: 3
Shanghai Tuojie Biotechnology Co., Ltd.
Shanghai Shi, China
Patent: 3
With the analysis among 2,038 patents, we discovered top 163 universities and scientific research institutions by total patent application. Duke University, The Scripps Research Institute, Emory University are dominant in this area. They take 16.88% of the total patent filing.
North Carolina, United States
Patent: 154
The Scripps Research Institute
California, United States
Patent: 74
Georgia, United States
Patent: 55
Shandong Sheng, China
Patent: 52
New York, United States
Patent: 39
Katholieke Universiteit Leuven
Vlaams-Brabant, Belgium
Patent: 35
The Trustees of Columbia University in The City of New York
New York, United States
Patent: 32
Connecticut, United States
Patent: 29
Icahn School of Medicine at Mount Sinai
New York, United States
Patent: 28
Tennessee, United States
Patent: 24